New cancer drug tested in humans for first time
Disease control
Terminated
This was an early-stage study to test a new cancer drug called LB101 in people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose and check for side effects. Researchers also looked for early signs that the drug …
Phase: PHASE1, PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC